Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Employment Law Update for August 2017
By Mike O'Brien bio
Here is my periodic update prepared for interested HR professionals trying to deal with the complex American employment laws…
POC HCV RNA Testing Key to Achieving National Viral Elimination Goals
From - Diagnostic Testing & Emerging Technologies
The Xpert HCV Viral Load test (Cepheid, Sunnyvale, Calif.) for hepatitis C virus (HCV) has good accuracy for detecting viral RNA using whole blood from a finger stick…
Labs Can Provide Novel Support for Physicians Ordering Multigene Panels
From - Diagnostic Testing & Emerging Technologies
As the price of sequencing continues to drop and genomic testing in oncology continues to shift towards larger panels, physicians have self-reported difficulty in…
HIV Testing Remains Low in Young Adults
From - Diagnostic Testing & Emerging Technologies
The United States is falling behind national goals to identify patients unaware of their positive HIV status and link them to care…
Publications Validate LDT for Sperm Function, as Measure of Fertility
...
Already a member? Log in here
C-reactive Protein May Inform Antidepressant Medication Selection
...
Already a member? Log in here
FDA Reports Progress in Advancing Regulatory Science for Diagnostics
From - Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration (FDA) recently unveiled its FY 2015-2016: Regulatory Science Progress Report. The report, the second of its kind under the…
Push-Alerts of Lab Results Speeds Discharge from Emergency Dept
From - Diagnostic Testing & Emerging Technologies
Smartphone push-alert notification of troponin laboratory results allow physicians to discharge patients seen in the…
FDA Speeding Approval Process, Continued User Fees Needed
From - Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration (FDA) is plagued with chronic understaffing, scrutiny over the length of time for approvals, and an expanding workload, while also…
Potential Upcoming Shifts for Diabetes-Related Diagnostic Testing
From - Diagnostic Testing & Emerging Technologies
New research suggests that potential shifts might occur in diabetes-related testing, including potential increased use of…
